Satchi-Fainaro R - Search Results

1

Polymer therapeutics--polymers as drugs, drug and protein conjugates and gene delivery systems: past, present and future opportunities.

Duncan R, Ringsdorf H, Satchi-Fainaro R. Duncan R, et al. J Drug Target. 2006 Jul;14(6):337-41. doi: 10.1080/10611860600833856. J Drug Target. 2006. PMID: 17092834 Review. No abstract available.

2

Professor Ruth Duncan: a pioneer in the field of polymer therapeutics.

Satchi-Fainaro R, Vicent MJ, Richardson S. Satchi-Fainaro R, et al. J Drug Target. 2017 Nov-Dec;25(9-10):757-758. doi: 10.1080/1061186X.2017.1371722. Epub 2017 Oct 9. J Drug Target. 2017. PMID: 28832230 No abstract available.

3

PDEPT: polymer-directed enzyme prodrug therapy. 2. HPMA copolymer-beta-lactamase and HPMA copolymer-C-Dox as a model combination.

Satchi-Fainaro R, Hailu H, Davies JW, Summerford C, Duncan R. Satchi-Fainaro R, et al. Bioconjug Chem. 2003 Jul-Aug;14(4):797-804. doi: 10.1021/bc020091k. Bioconjug Chem. 2003. PMID: 12862433

4

HPMA copolymer-phospholipase C and dextrin-phospholipase A2 as model triggers for polymer enzyme liposome therapy (PELT).

Ferguson EL, Scomparin A, Hailu H, Satchi-Fainaro R. Ferguson EL, et al. J Drug Target. 2017 Nov-Dec;25(9-10):818-828. doi: 10.1080/1061186X.2017.1358726. Epub 2017 Aug 10. J Drug Target. 2017. PMID: 28728446

5

Integrin-targeted nano-sized polymeric systems for paclitaxel conjugation: a comparative study.

Eldar-Boock A, Blau R, Ryppa C, Baabur-Cohen H, Many A, Vicent MJ, Kratz F, Sanchis J, Satchi-Fainaro R. Eldar-Boock A, et al. J Drug Target. 2017 Nov-Dec;25(9-10):829-844. doi: 10.1080/1061186X.2017.1358727. Epub 2017 Aug 8. J Drug Target. 2017. PMID: 28737432

6

Current hurdles to the translation of nanomedicines from bench to the clinic.

Đorđević S, Gonzalez MM, Conejos-Sánchez I, Carreira B, Pozzi S, Acúrcio RC, Satchi-Fainaro R, Florindo HF, Vicent MJ. Đorđević S, et al. Drug Deliv Transl Res. 2022 Mar;12(3):500-525. doi: 10.1007/s13346-021-01024-2. Epub 2021 Jul 23. Drug Deliv Transl Res. 2022. PMID: 34302274 Free PMC article. Review.

7

Two-step polymer- and liposome-enzyme prodrug therapies for cancer: PDEPT and PELT concepts and future perspectives.

Scomparin A, Florindo HF, Tiram G, Ferguson EL, Satchi-Fainaro R. Scomparin A, et al. Adv Drug Deliv Rev. 2017 Sep 1;118:52-64. doi: 10.1016/j.addr.2017.09.011. Epub 2017 Sep 12. Adv Drug Deliv Rev. 2017. PMID: 28916497 Review.

8

Clinically-relevant and predictive cancer models for nanomedicine evaluation.

Satchi-Fainaro R, Florindo HF, Vicent MJ. Satchi-Fainaro R, et al. Adv Drug Deliv Rev. 2022 Apr;183:114140. doi: 10.1016/j.addr.2022.114140. Epub 2022 Feb 5. Adv Drug Deliv Rev. 2022. PMID: 35134434 No abstract available.

9

Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470.

Satchi-Fainaro R, Puder M, Davies JW, Tran HT, Sampson DA, Greene AK, Corfas G, Folkman J. Satchi-Fainaro R, et al. Nat Med. 2004 Mar;10(3):255-61. doi: 10.1038/nm1002. Epub 2004 Feb 22. Nat Med. 2004. PMID: 14981512 Free article.

10

Synthesis and characterization of a catalytic antibody-HPMA copolymer-Conjugate as a tool for tumor selective prodrug activation.

Satchi-Fainaro R, Wrasidlo W, Lode HN, Shabat D. Satchi-Fainaro R, et al. Bioorg Med Chem. 2002 Sep;10(9):3023-9. doi: 10.1016/s0968-0896(02)00156-6. Bioorg Med Chem. 2002. PMID: 12110325

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

125 results

Search Page